biguanides has been researched along with Psoriasis in 3 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Psoriasis is a common chronic inflammatory skin disease that manifests as scaly erythematous plaques as a consequence of keratinocyte hyperproliferation and inflammation." | 2.55 | Glycemic Control in the Treatment of Psoriasis. ( Ip, W; Kirchhof, MG, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ip, W | 1 |
| Kirchhof, MG | 1 |
| Klode, J | 1 |
| Körber, A | 1 |
| Dissemond, J | 1 |
| Laloux, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Metformin for Treatment of Psoriasis Combined With Disorders of Glucose and Lipid Metabolism: A Double-Blind, Randomized, Placebo-Controlled Study[NCT03629639] | Phase 4 | 80 participants (Anticipated) | Interventional | 2018-09-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for biguanides and Psoriasis
| Article | Year |
|---|---|
Glycemic Control in the Treatment of Psoriasis.
Topics: Biguanides; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide-1 Receptor; Humans; | 2017 |
2 other studies available for biguanides and Psoriasis
| Article | Year |
|---|---|
[Psoriasis vulgaris as a trigger for a superficial multilocular pyoderma gangrenosum?].
Topics: Biguanides; Dermatologic Agents; Diagnosis, Differential; Humans; Male; Middle Aged; Psoriasis; Pyod | 2009 |
[Dermatologic study of a new ointment: Dexatopic].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Biguanides; Child; Child, Preschool; Dermatitis; | 1971 |